Harm Reduction Toolkit for Non-Prescription Syringe Sales in Community Pharmacies

The purpose of this project is to demonstrate how the tools developed by the Offeror in SBIR Phase I can be scaled up to support pharmacy-based syringe programs and harm reduction services. This Phase II project shall build upon the findings of the SBIR Phase I research and expand into operational research. Offeror shall complete development of tools to support harm reduction services within pharmacies. The Offeror shall also conduct a demonstration project, that includes several pharmacies, to determine how pharmacists can utilize the aforementioned tools to provide harm reduction services. The demonstration project shall be evaluated and include a qualitative assessment of the acceptability and usability of the tools, by pharmacy staff and by PWID. The following are the required results of this contract: • Finalize harm reduction kit for PWID • Complete development of the online training for pharmacists and pharmacy personnel • Complete suite of internet resources for PWIDs who access the harm reduction kit • Conduct a demonstration project to show the acceptability and usability of the aforementioned tools (bullets 1-3) for harm reduction • Evaluate the demonstration project